SCHEDULE: FMR LLC Discloses 10.8% Stake in Caris Life Sciences

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.8% in Caris Life Sciences Inc. as of March 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Caris Life Sciences Inc. common stock.
• As of March 31, 2026, the reporting persons collectively beneficially own 30,631,585 shares, representing 10.8% of the class of securities.
• FMR LLC, organized in Delaware, is classified as a holding company (HC).
• Abigail P. Johnson, a U.S. citizen, is classified as an insider (IN).
• The filing indicates that while FMR LLC has sole voting power of 30,592,295 shares, both FMR LLC and Abigail P. Johnson share sole dispositive power over 30,631,585 shares.
• The filing also notes that one or more other persons have the right to receive or direct the receipt of dividends or proceeds from the sale of these securities, but no single other person's interest exceeds five percent.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a significant ownership stake but provides no new financial performance data or strategic insights that would inherently sway sentiment.

Positives

• Significant institutional ownership by FMR LLC and Abigail P. Johnson, indicating confidence in the company.
• Clear disclosure of beneficial ownership, adhering to regulatory requirements.

Negatives

• The filing does not contain specific financial performance data, only ownership stakes.

Risks

• The filing does not explicitly mention any risks.
• Potential for future changes in ownership stake by FMR LLC or Abigail P. Johnson could impact share price.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance. It solely reports current ownership status.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in public companies. This filing indicates FMR LLC's continued interest in Caris Life Sciences Inc., a player in the life sciences sector, which is characterized by innovation and significant capital investment.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by FMR LLC may be viewed positively, suggesting institutional confidence, but it does not directly impact current share value without further context.
• Management: The filing confirms FMR LLC's non-control-oriented investment approach.
• Creditors: No direct impact is indicated.

Next Steps

• Continued monitoring of FMR LLC's ownership stake in Caris Life Sciences Inc. for any future changes or disclosures.

Key Dates

Keywords

Schedule 13G, FMR LLC, Abigail P. Johnson, Caris Life Sciences Inc, beneficial ownership, common stock, institutional investor, SEC filing